Drug Shortages, Newly Developed Therapies, and Access 

ASH provides the following resources to keep physicians informed of newly approved therapies, safety and prescription matters, and shortages of critical hematologic drugs.

Hematologic Risk Evaluation and Mitigation Strategies

Information about hematologic risk evaluation and mitigation strategies (REMs)

Learn more

High-Cost Hematologic Drug Access

Resources to help clinicians and patients access high-cost hematologic drugs

Learn more

Hematologic Drug Shortage Information

Information and resources regarding shortages of drugs used to treat patients with hematologic diseases

Learn more